Drug
CRV-431 clinical trials
Also written CRV431.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How studies write it
Studies that test it under each name
Development codes
Other names
Studies by the year they started
5 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 1
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Hepion Pharmaceuticals, Inc. (5)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses CRV-431 is read from its arms, and is right about nine times in ten.
Testing it · 5
- Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male SubjectsCompletedEarly Phase 1Hepion Pharmaceuticals, Inc.NCT05737433Written as [14C]-rencofilstat 225mg
- A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3CompletedPhase 2Hepion Pharmaceuticals, Inc.NCT05461105Written as rencofilstat, 75 mg
- A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver FibrosisStatus unknownPhase 2Hepion Pharmaceuticals, Inc.NCT05402371Written as Rencofilstat
- A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 SubjectsCompletedPhase 2Hepion Pharmaceuticals, Inc.NCT04480710Written as CRV431 75mg
- A Study in Healthy VolunteersCompletedPhase 1Hepion Pharmaceuticals, Inc.NCT03596697Written as CRV431